The James P. Allison Institute at MD Anderson Cancer Center established an 11-person scientific advisory board to provide strategic guidance and evaluation of its research portfolio and programs.
Treatment with a combination of haloperidol and lorazepam reduced symptoms of agitated delirium, a common end-of-life condition for patients with advanced cancers, compared with haloperidol alone, according to a study led by researchers at The University of Texas MD Anderson Cancer Center.
